- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04054739
Cortical Activity and Gait Function for Robotic Gait Training in Hemiparetic Stroke
9 februari 2020 bijgewerkt door: Joon-Ho Shin, National Rehabilitation Center, Seoul, Korea
Effects of Robotic Gait Training on Cortical Activity and Gait Function in Hemiparetic Stroke
Effects of robot-assisted gait training on cortical activity and gait function in hemiparetic stroke
Studie Overzicht
Toestand
Voltooid
Conditie
Interventie / Behandeling
Studietype
Ingrijpend
Inschrijving (Werkelijk)
30
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
-
Seoul, Korea, republiek van, 142884
- National Rehabilitation Center
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
19 jaar en ouder (Volwassen, Oudere volwassene)
Accepteert gezonde vrijwilligers
Nee
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- Hemiplegic patients secondary to first cerebrovascular accidents
- Functional ambulation category score 3
- 3 months ≤ Onset ≤ 12 months
- Korean Mini-Mental State Examination score > 24
Exclusion Criteria:
- History of surgery of affected lower limb
- Fracture of affected lower limb
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Robot-assisted gait training
experimental group that applied the end-effector robot-assisted gait training
|
intervention with robot-assisted gait training
|
|
Actieve vergelijker: Treadmill gait training
control group that applied the treadmill gait training
|
intervention with treadmill gait training
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
oxygenated hemoglobin levels
Tijdsspanne: 4 weeks from baseline
|
cortical activity of primary sensorimotor cortex, premotor cortex, supplementary motor areas, pre-supplementary motor areas, prefrontal cortex during gait
|
4 weeks from baseline
|
|
Range of motion of ankle, knee, and hip joint
Tijdsspanne: 4 weeks from baseline
|
ankle, knee, and hip joint motion of sagittal plane during gait
|
4 weeks from baseline
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
oxygenated hemoglobin levels
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
cortical activity of primary sensorimotor cortex, premotor cortex, supplementary motor areas, pre-supplementary motor areas, prefrontal cortex during gait
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
Range of motion of ankle, knee, and hip joint
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
ankle, knee, and hip joint motion of sagittal plane during gait
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
Berg Balance Scale
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Berg Balance Scale assess the functional balance ability of participants with observation of 14 tasks, representing functional movements common in daily life.
Each task is scored on a five-point scale (0-4) following the guidelines of the test developers, and the maximum score on this test is 56 which indicates balance ability within the normal range.
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
Fugl-Meyer Assessment
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Fugl-Meyer Assessment uses to examine the motor function and coordination of affected lower extremity.
It includes 17 items of a 3-point ordinal scale, ranging 0-34, with higher scores indicating lower impairment.
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
10m walk test
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
10m walk test is used to examine gait speed, in which participant was asked to walk on a 14 meter of walkway wearing harness with two conditions; with the fastest speed or with self-selected comfortable speed.
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
Functional ambulation category
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Functional Ambulation Category is used to assess gait ability with 6 levels ranging from 0 to 5 on the basis of the amount of physical support required, regardless of use of an assistive device
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
Falls efficacy scale
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Korean version of Falls efficacy scale asks subjects to rank their confidence about their ability not to fall while performing a variety of activities of daily living with a maximum score of 100
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
Beck depression inventory
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
21-question multiple-choice self-report inventory, one of the most widely used psychometric tests
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
Stroke impact scale
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
health-related quality of life poststroke across 8 domains using a 5-point Likert scale, with the score ranging from 0 to 100 and a higher score indicating better health status
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
Dynamic gait index
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
a clinical tool to assess gait, balance and fall risk
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
Timed up and go test
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
a simple test used to assess a person's mobility and requires both static and dynamic balance
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
modified Barthel index
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Measure of physical disability used widely to assess behaviour relating to activities of daily living for stroke patients
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
dual task - COWAT
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Controlled Oral Word Association Test, abbreviated COWA or COWAT, is a verbal fluency test that measures spontaneous production of words belonging to the same category or beginning with some designated letter.
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
dual task - digit span test
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
The digit span test is a way of measuring the storage capacity of a person's working memory.
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
Electromyography of lower extremities
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Muscle activity of tibialis anterior, medial gastrocnemius, vastus medialis, biceps femoris, gluteus medius during gait.
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
Plantar pressure
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Plantar pressure (great toe, little toe, medial meta, lateral meta, medial arch, lateral arch, heel) during gait
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
Spatiotemporal gait parameter data
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
step length, step time, swing time, double limb support time during gait
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
deoxygenated hemoglobin levels
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
cortical activity of primary sensorimotor cortex, premotor cortex, supplementary motor areas, pre-supplementary motor areas, prefrontal cortex during gait
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
total hemoglobin levels
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
cortical activity of primary sensorimotor cortex, premotor cortex, supplementary motor areas, pre-supplementary motor areas, prefrontal cortex during gait
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
|
Balance test using force plate
Tijdsspanne: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Static standing balance as measured using a force plate: Changes in center-of-pressure velocity and area
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Publicaties en nuttige links
De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Werkelijk)
1 september 2018
Primaire voltooiing (Werkelijk)
30 november 2019
Studie voltooiing (Werkelijk)
31 december 2019
Studieregistratiedata
Eerst ingediend
12 augustus 2019
Eerst ingediend dat voldeed aan de QC-criteria
12 augustus 2019
Eerst geplaatst (Werkelijk)
13 augustus 2019
Updates van studierecords
Laatste update geplaatst (Werkelijk)
11 februari 2020
Laatste update ingediend die voldeed aan QC-criteria
9 februari 2020
Laatst geverifieerd
1 februari 2020
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- NRC-2017-02-015
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Nee
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
product vervaardigd in en geëxporteerd uit de V.S.
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .